These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3896219)

  • 1. Comparison of immune response stimulated in sheep, rabbits and guinea pigs by the administration of multi-component clostridial vaccines.
    Webster AC; Frank CL
    Aust Vet J; 1985 Apr; 62(4):112-4. PubMed ID: 3896219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 3. An alternative to the toxin neutralization assay in mice for the potency testing of the Clostridium tetani, Clostridium septicum, Clostridium novyi type B and Clostridium perfringens type D epsilon components of multivalent sheep vaccines.
    Wood KR
    Biologicals; 1991 Oct; 19(4):281-6. PubMed ID: 1797039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between the rabbit potency test and the response of sheep to sheep clostridial vaccines.
    Frerichs GN; Gray AK
    Res Vet Sci; 1975 Jan; 18(1):70-5. PubMed ID: 164058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency testing of Clostridium septicum bacterins in sheep and laboratory animals.
    Cardella MA; Kolbe DR
    Dev Biol Stand; 1976; 32():115-22. PubMed ID: 1001825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection site reactions and antibody responses in sheep and goats after the use of multivalent clostridial vaccines.
    Green DS; Green MJ; Hillyer MH; Morgan KL
    Vet Rec; 1987 May; 120(18):435-9. PubMed ID: 2885963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.
    Fathi Najafi M; Rahman Mashhadi M; Hemmaty M
    Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A contribution on the active and passive vaccination against Clostridium novyi and Clostridium tetani].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):350-6. PubMed ID: 4233547
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporal evolution of anti-Clostridium antibody responses in sheep after vaccination with polyvalent clostridial vaccines.
    Rossi A; Mónaco A; Guarnaschelli J; Silveira F; Iriarte A; Benecke AG; Chabalgoity JA
    Vet Immunol Immunopathol; 2018 Aug; 202():46-51. PubMed ID: 30078598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standards for Clostridium chauvoei vaccine--the relationship between the response of guinea pigs and sheep following vaccination and challenge with virulent C. chauvoei.
    Crichton R; Harriss DA; McKay DJ
    Aust Vet J; 1986 Mar; 63(3):68-70. PubMed ID: 3729832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of Clostridium septicum alpha-toxoid vaccine against challenge with spores in guinea pigs.
    Amimoto K; Ohgitani T; Sasaki O; Oishi E; Katayama S; Isogai M; Ota S
    J Vet Med Sci; 2002 Jan; 64(1):67-9. PubMed ID: 11853149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation to Clostridium septicum toxoid.
    Kennedy K
    Dev Biol Stand; 1976; 32():123-30. PubMed ID: 1001826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens.
    Crichton R; Solomon J; Barton AM
    Biologicals; 1990 Jan; 18(1):49-54. PubMed ID: 2317354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a multicomponent standard for clostridial vaccines.
    Gray AK
    Dev Biol Stand; 1976; 32():245-50. PubMed ID: 187507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The titration of clostridial toxoids and antisera in cell culture.
    Knight PA; Burnett C; Whitaker AM; Queminet J
    Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.